Xiaomei Liu

Title: Innovations and Contributions of Inventor Xiaomei Liu

Introduction

Xiaomei Liu is a notable inventor based in Flushing, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of new pharmaceutical compounds. With a total of 3 patents, her work focuses on creating effective treatments for various types of cancer.

Latest Patents

One of her latest patents is titled "Class of quinolone heterocyclic aromatic molecules for cancer treatment." This invention introduces a new class of quinolone heterocyclic aromatic molecules, known as Renotinibs, which are designed to target and treat cancers that harbor abnormal human epidermal growth factor receptors (EGFRs). Another significant patent is for "Derivatives of isoindigo, indigo and indirubin and methods of treating cancer." This patent describes a compound called NATURA, a derivative of Isoindigo, which aids in the general health of patients and is particularly beneficial in preventing or treating cancer. The patent also covers methods for synthesizing these derivatives and pharmaceutical compositions that include a therapeutically effective amount of these compounds.

Career Highlights

Throughout her career, Xiaomei Liu has worked with various companies, including Natrogen Therapeutics, Inc. Her innovative approach and dedication to cancer research have positioned her as a key figure in the development of new therapeutic options.

Collaborations

Xiaomei has collaborated with notable colleagues such as Longgui Wang and Ruihuan Chen. These collaborations have further enhanced her research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Xiaomei Liu's contributions to cancer treatment through her innovative patents and collaborations highlight her significant role in the field of medical research. Her work continues to pave the way for new therapeutic options that can improve patient outcomes.